Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S I Sherman

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 11, 2010
Cytotoxic chemotherapy for differentiated thyroid carcinomaS I Sherman
Seminars in Surgical Oncology|January 16, 1999
Adjuvant therapy and long-term management of differentiated thyroid carcinomaS I Sherman
Seminars in Surgical Oncology|January 16, 1999
Toward a standard clinicopathologic staging approach for differentiated thyroid carcinomaS I Sherman
European Journal of Endocrinology|September 6, 2011
Approach to the patient with advanced differentiated thyroid cancerM Schlumberger, S I Sherman
Thyroid : Official Journal of the American Thyroid Association|September 16, 1998
Effects of pharmacological fiber supplements on levothyroxine absorptionA C Chiu, S I Sherman
The Journal of Clinical Endocrinology and Metabolism|September 1, 1992
Organ-specific effects of tiratricol: a thyroid hormone analog with hepatic, not pituitary, superagonist effectsS I Sherman, P W Ladenson
Journal of Endocrinological Investigation|March 1, 1992
Octreotide therapy of growth hormone excess in the McCune-Albright syndromeS I Sherman, P W Ladenson
The American Journal of Medicine|March 1, 1991
Percutaneous transluminal coronary angioplasty in hypothyroidismS I Sherman, P W Ladenson
The American Journal of Medicine|August 1, 1996
Clinical and socioeconomic predispositions to complicated thyrotoxicosis: a predictable and preventable syndrome?S I Sherman, L Simonson, P W Ladenson
The Journal of Clinical Endocrinology and Metabolism|November 14, 1997
Prognosis and treatment of brain metastases in thyroid carcinomaA C Chiu, E S Delpassand, S I Sherman
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 11, 2010
Cytotoxic chemotherapy for differentiated thyroid carcinomaS I Sherman
Seminars in Surgical Oncology|January 16, 1999
Adjuvant therapy and long-term management of differentiated thyroid carcinomaS I Sherman
Seminars in Surgical Oncology|January 16, 1999
Toward a standard clinicopathologic staging approach for differentiated thyroid carcinomaS I Sherman
European Journal of Endocrinology|September 6, 2011
Approach to the patient with advanced differentiated thyroid cancerM Schlumberger, S I Sherman
Thyroid : Official Journal of the American Thyroid Association|September 16, 1998
Effects of pharmacological fiber supplements on levothyroxine absorptionA C Chiu, S I Sherman
The Journal of Clinical Endocrinology and Metabolism|September 1, 1992
Organ-specific effects of tiratricol: a thyroid hormone analog with hepatic, not pituitary, superagonist effectsS I Sherman, P W Ladenson
Journal of Endocrinological Investigation|March 1, 1992
Octreotide therapy of growth hormone excess in the McCune-Albright syndromeS I Sherman, P W Ladenson
The American Journal of Medicine|March 1, 1991
Percutaneous transluminal coronary angioplasty in hypothyroidismS I Sherman, P W Ladenson
The American Journal of Medicine|August 1, 1996
Clinical and socioeconomic predispositions to complicated thyrotoxicosis: a predictable and preventable syndrome?S I Sherman, L Simonson, P W Ladenson
The Journal of Clinical Endocrinology and Metabolism|November 14, 1997
Prognosis and treatment of brain metastases in thyroid carcinomaA C Chiu, E S Delpassand, S I Sherman
Pageof 4